Wang, L.; Ding, Z.; Wang, Z.; Zhao, Y.; Wu, H.; Wei, Q.; Gao, L.; Han, J.
The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability. Pharmaceutics 2024, 16, 109.
https://doi.org/10.3390/pharmaceutics16010109
AMA Style
Wang L, Ding Z, Wang Z, Zhao Y, Wu H, Wei Q, Gao L, Han J.
The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability. Pharmaceutics. 2024; 16(1):109.
https://doi.org/10.3390/pharmaceutics16010109
Chicago/Turabian Style
Wang, Lili, Zhuang Ding, Zhengping Wang, Yanna Zhao, Hengqian Wu, Qipeng Wei, Lingfeng Gao, and Jun Han.
2024. "The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability" Pharmaceutics 16, no. 1: 109.
https://doi.org/10.3390/pharmaceutics16010109
APA Style
Wang, L., Ding, Z., Wang, Z., Zhao, Y., Wu, H., Wei, Q., Gao, L., & Han, J.
(2024). The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability. Pharmaceutics, 16(1), 109.
https://doi.org/10.3390/pharmaceutics16010109